Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/10/2002US20020146414 Controlled release of non heparin-binding growth factors from heparin-containing matrices
10/10/2002US20020146411 Anticoagulant agents useful in treatment of thrombosis
10/10/2002US20020146409 Providing a blood protein solution; adding hydroxypropyl-alpha -cyclodextrin in to form a stable complex with the protein; lyophilizing the solution of step to form a lyophilized protein/hydroxypropyl- alpha -cyclodextrin complex
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146407 For therapy and prophylaxis of dysfunctions or diseases including, but not limited to, asthma, airway allergy, chronic obstructive pulmonary disease
10/10/2002US20020146406 Polypeptides with therapeutic activity and methods of use
10/10/2002US20020146405 Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide
10/10/2002US20020146404 Treating method for suppressing hair growth
10/10/2002US20020146403 Method for the treatment of bacterial eye infections
10/10/2002US20020146402 Method for the treatment of bacterial vaginal infections
10/10/2002US20020146397 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146390 Therapy of sepsis and adult respiratory distress syndrome using chemokine or biologically active fragment thereof, alone or in conjunction with an anti-infective agent
10/10/2002US20020146389 For inducing apoptosis in mammalian cancer cells; stimulating a proinflammatory response in mammalian cells
10/10/2002US20020146388 Cytokine immunoconjugates
10/10/2002US20020146374 For therapy of candidiasis
10/10/2002US20020146373 Administering to the respiratory system of a patient or animal hormone aerodynamically light particles, wherein particles are delivered and deposited to patient's or animal's lungs and hormone is released in patient's or animal's blood stream
10/10/2002US20020146372 Obtaining aerosolizable topical insulin and obtaing short-acting oral hypoglycemic agent having aduration of action shorter than long-acting oral hypoglycemic agents; utilizing insulin and ingesting oral hypoglycemic agent
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002DE10115668A1 Agent for treating stroke, blood flow disorders and accumulation of blood in tissues, comprises kinin B1 receptor stimulant, e.g. interleukin-1beta, des-(Arg-9)-bradykinin or captopril
10/10/2002DE10115310A1 Bakteriophagen-Präparation Bacteriophage preparation
10/10/2002DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002DE10114178A1 Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität Zinc-free and low-zinc insulin preparations with improved stability
10/10/2002DE10108412A1 Ocular pigment epithelial cells, useful for treating e.g. macular degeneration by implantation, are transformed with large-capacity adenoviral vector
10/10/2002CA2795396A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002CA2445499A1 Fizz1 for metabolism regulation
10/10/2002CA2443324A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2443179A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2443176A1 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002CA2442944A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442847A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442838A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442835A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002CA2442808A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442619A1 Cancer-testis antigens
10/10/2002CA2442540A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease
10/10/2002CA2442532A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002CA2442531A1 Peptides and antibodies to muc 1 proteins
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442363A1 Reducing the immunogenicity of fusion proteins
10/10/2002CA2442177A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002CA2442149A1 Viral vectors
10/10/2002CA2442134A1 Compositions and methods for diagnosing or treating psoriasis
10/10/2002CA2442123A1 Adp-ribosylating bacterial toxins
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002CA2441654A1 Cytoskeleton-associated proteins
10/10/2002CA2441562A1 Short bioactive peptides and methods for their use
10/10/2002CA2441335A1 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2435828A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2434677A1 Molecules for diagnostics and therapeutics
10/10/2002CA2429108A1 .psi..epsilon.rack peptide composition and method for protection against tissue damage due to ischemia
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247864A2 58297, an amino acid transporter and uses therefor
10/09/2002EP1247862A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002EP1247817A2 Human CD23-like protein and nucleic acids encoding it
10/09/2002EP1247532A1 Composition promoting lacrimal secretion
10/09/2002EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002EP1247530A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247100A1 Interaction between cd14 and hbv components
10/09/2002EP1246929A2 Methods and compositions for obtaining disease protection for animals
10/09/2002EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002EP1246923A2 Dna modification proteins
10/09/2002EP1246919A1 Progenitor cell preservation factors and related methods and products
10/09/2002EP1246918A2 Secreted proteins
10/09/2002EP1246917A2 Human stra6 polypeptides
10/09/2002EP1246916A2 26904, 38911, and 39404, seven-transmembrane proteins / g-protein coupled receptors
10/09/2002EP1246915A2 Improved lysosomal enzymes and lysosomal enzyme activators
10/09/2002EP1246912A2 Antisense oligonucleotide sequences derived from groel and groes as inhibitors of microorganisms
10/09/2002EP1246905A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use
10/09/2002EP1246901A1 Methods for protein transfer
10/09/2002EP1246846A2 Soluble interleukin-20 receptor
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246839A1 Depsipeptide and congeners thereof for use as immunosuppressants
10/09/2002EP1246838A1 Lipopeptides as antibacterial agents
10/09/2002EP1246836A2 Peptides for treatment of erectile dysfunction
10/09/2002EP1246834A1 Epididymal antimicrobial peptides
10/09/2002EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002EP1246792A1 Compounds and compositions for delivering active agents
10/09/2002EP1246649A1 Intravascular delivery of nucleic acid
10/09/2002EP1246645A2 A stable immunogenic composition for frozen storage
10/09/2002EP1246644A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
10/09/2002EP1246642A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
10/09/2002EP1246641A2 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
10/09/2002EP1246640A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
10/09/2002EP1246639A2 Glp-2 formulations
10/09/2002EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
1 ... 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 ... 3163